Skinbiotherapeutics Share Discussion Threads

[danatkins] 01/12/2018 11:33

Surly anyone planning to attend on Monday found have already researched the company as there is already alot of info out there and Monday's presentation will be a rehash of past presentations

[gostaa] 01/12/2018 01:41

slartybartfaster, if you are correct then we could see a sell off on Tuesday. Please be wrong!

[slartybartfaster] 30/11/2018 19:08

No, the rise has an obvious reason for it. Traders speculating on the investor presentation on Monday. I think a few opti pi sold today to add SBTX.

[rafboy] 30/11/2018 16:18

The trial has only been going 10 days or so and doesn’t complete until end Q1 next year so I feel sure there is no leak.

[matt123d] 30/11/2018 15:02

Nice move, see if there's appetite to push it above 20p.

[rathean] 30/11/2018 15:00

I doth my cap to a gent with greater knowledge, nice momentum buying today, let's hope we see mid-20s before Xmas and the kids will be getting pressies after all :)

[riskybusiness1] 30/11/2018 13:38

The trials are double blinded equivalent to phase 2 pharma, similar to Optibiotix LPLDL first study but will give a more comprehensive idea on its efficacy due to having 100+ subjects in comparison to 50.The science has been proven in laboratory in live skin which stays alive outside of the body for weeks. We know it works but questions remain temporarily unanswered on how it reacts on skin attached to a living person. Safety and tolerance probably the biggest risk which has passed. Chances of it working well as the data has already shown is very high but there is always a risk in clinical trials.My moneys on a substantial uplift in value here next quarter. By substantial I'm talking minimum double current value, momentum traders could see it well above 50p

[rathean] 30/11/2018 13:12

Point is this is not a clinical trial as per pharma so the bar is lower. Given the success OPTI has had in recent days with its product status and this is from the same stable I'd be genuinely surprised if the trial is not a green light for commercialisation imo dyor ofc.

[parob] 30/11/2018 12:50

Nothing is guaranteed but I reckon there's a 95% chance of good data and I can see this easily double this price on the news - the risk reward is good enough for me to take a decent stake!

[montynj] 30/11/2018 12:47

Is this a real shoo in to get good data on trial ?

[parob] 30/11/2018 12:30

I've been buying between 15.5 to 17.5p. Think this has bottomed and pretty sure it will mirror OPTI's chart as that rises over next few weeks with news flow.

[montynj] 30/11/2018 12:29

Nice bowl shape on chart which is always a bullish sign

[someuwin] 29/11/2018 10:15

"There are now just ten seats left at the UK Investor Show team's next City forum which takes place on the evening of Monday 3rd December in the heart of the City of London at the headquarters of investment bank UBS. There’s mince pies, wine and canapes on offer but more importantly the event features presentations and a chance to quiz three growth companies: SkinBioTherapeutics, RiverFort Global Opportunities (formerly Paternoster Resources) and Sosandar. The evening ends with our own, Chris “Three Brains” Bailey, interviewing Britain's Buffett Nigel Wray.

The event starts at 5.30PM on Monday 3rd December with the talks commencing at 6PM. There will be a chance to chat to all the speakers in an informal session, with more drinks and canapes after the talks. Places are limited and there are now just ten seats left. To book your free seat click HERE

AIM listed fashion company Sosandar sees itself as the new destination for women’s clothing, fusing shopping with exclusive daily fashion news and style advice. Created by women, for women. Its shares have doubled since their IPO less than a year ago.

SkinBioTherapeutics Plc is a life science company focused on skin health spun off by Optibiotix. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CEO, Prof. Cathy O’Neill and Prof. Andrew McBain.

RiverFort Global Opportunities gives AIM investors a unique way of getting exposure to the sort of structured finance many AIM companies utilise.

To discover what the excitement is about for these three companies and to hear Nigel and Chris in conversation, book your complimentary seats now. There are now just ten seats left To book your free seat click HERE"

[jammyjim] 28/11/2018 08:31

A nice slow and steady rise before results. Leading to a scramble for shares on the good news. It will only take one bit of good news similar to Opti and this Share will double in price. Grab them while you can.

[danatkins] 28/11/2018 00:40

Perfect - was concerned we'd fall through support. Opti news has fueled investors minds on what's possible. Our chairman is a very clever man and of course the companies CEO comes across well. Like to see a general market shift to the upside over the next month then if we can get initial great results then these prices maybe history

[slartybartfaster] 27/11/2018 21:29

? I've been waiting for this.

[anderson3] 27/11/2018 13:37

I've just taken profit on skin to buy opti

[rathean] 27/11/2018 13:07

Just taken profits in OPTI, sticking around here longer term. Upside here very exciting imo dyor ofc.

[rathean] 27/11/2018 10:32

Imo this will slowly recover towards its previous highs ahead of trial results. But on rumour and hopefully not sell on facts...

[semper vigilans] 27/11/2018 09:20

....or the bottom looks to have charted?

[montynj] 27/11/2018 09:13

Chart looks to have bottomed here

[matt123d] 27/11/2018 08:29

Flipped to the long side here looking for 18/19.

[onedayrodders] 26/11/2018 06:31

Interesting trading update from SKIN which has a positive mention of the microbiome ..

[slartybartfaster] 23/11/2018 08:42

? That still makes me laugh when you and risky remind us of Raywhack superior knowledge of his understanding of the science. Apart from his sweepstake opinion on HH flow rate and bopd its must be one of his best quotes.